Biolife Solutions (BLFS) Net Equity Issued and Repurchased (2014 - 2020)
Biolife Solutions (BLFS) posted quarterly Net Equity Issued and Repurchased of -$130000.0 for Q4 2020, down 100.16% quarter-over-quarter from $80.3 million in Q3 2020.
Biolife Solutions (BLFS) Net Equity Issued and Repurchased (2014 - 2020) Analysis & Trends
Biolife Solutions (BLFS) has reported Net Equity Issued and Repurchased for 2 consecutive years, with -$130000.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Net Equity Issued and Repurchased changed N/A year-over-year to -$130000.0; the TTM figure through Dec 2021 stood at $80.2 million (changed 0.0% YoY), while the FY2023 annual figure was $10.2 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased declined to -$130000.0 in Q4 2020 per BLFS's latest filing, from $80.3 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $80.3 million in Q3 2020 and bottomed at -$130000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 29.31 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -130,000.00 |
| Dec 31, 2020 | -130,000.00 |
| Sep 30, 2020 | 80.34 Mn |
| Sep 30, 2020 | 80.34 Mn |
| Mar 31, 2014 | 13.60 Mn |
| Mar 31, 2014 | 13.60 Mn |